Brief: Processa Pharmaceuticals To Effect 1-For-25 Reverse Stock Split
15/12/2025 16:47
Dec 15 (Reuters) - Processa Pharmaceuticals Inc PCSA.O: PROCESSA PHARMACEUTICALS INC - ON DEC 12, FILES CERTIFICATE OF AMENDMENT TO CO'S FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION PROCESSA PHARMACEUTICALS INC - TO EFFECT 1-FOR-25 REVERSE STOCK SPLIT - SEC FILING Source text: [ID:n0001493152-25-027680] Further company coverage: PCSA.O ((((Reuters.Briefs@thomsonreuters.com));))